| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 6.88e-07 | 15 | 24 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 1.03e-06 | 17 | 24 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.55e-05 | 48 | 24 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.06e-05 | 56 | 24 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 4.96e-05 | 9 | 24 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 1.16e-03 | 42 | 24 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.39e-03 | 46 | 24 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.44e-03 | 188 | 24 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | NAD binding | 3.45e-03 | 73 | 24 | 2 | GO:0051287 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.66e-03 | 891 | 24 | 5 | GO:0005198 | |
| GeneOntologyMolecularFunction | collagen binding | 4.23e-03 | 81 | 24 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | myosin binding | 4.65e-03 | 85 | 24 | 2 | GO:0017022 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.03e-04 | 418 | 24 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | protein homooligomerization | 1.21e-04 | 224 | 24 | 4 | GO:0051260 | |
| GeneOntologyCellularComponent | RNA cap binding complex | 1.70e-04 | 17 | 24 | 2 | GO:0034518 | |
| HumanPheno | Dysphonia | 1.31e-05 | 159 | 6 | 4 | HP:0001618 | |
| HumanPheno | Maladaptive fear-related cognitions | 4.16e-05 | 483 | 6 | 5 | HP:5200230 | |
| HumanPheno | Anxiety | 4.16e-05 | 483 | 6 | 5 | HP:0000739 | |
| HumanPheno | Abnormal judgment | 5.76e-05 | 516 | 6 | 5 | HP:5200401 | |
| HumanPheno | Abnormal fear-induced behavior | 7.08e-05 | 538 | 6 | 5 | HP:0100852 | |
| HumanPheno | Cachexia | 1.41e-04 | 100 | 6 | 3 | HP:0004326 | |
| HumanPheno | Abnormal experience of reality | 1.74e-04 | 646 | 6 | 5 | HP:5200423 | |
| HumanPheno | Constitutional symptom | 2.45e-04 | 1276 | 6 | 6 | HP:0025142 | |
| HumanPheno | Proximal muscle weakness | 2.63e-04 | 340 | 6 | 4 | HP:0003701 | |
| HumanPheno | Pointed chin | 3.67e-04 | 138 | 6 | 3 | HP:0000307 | |
| HumanPheno | Perseverative thought | 3.93e-04 | 377 | 6 | 4 | HP:0030223 | |
| HumanPheno | Disordered formal thought process | 4.31e-04 | 386 | 6 | 4 | HP:0025769 | |
| HumanPheno | Abnormal thought pattern | 5.14e-04 | 404 | 6 | 4 | HP:5200269 | |
| MousePheno | increased pancreatic beta cell apoptosis | 5.42e-05 | 8 | 20 | 2 | MP:0014117 | |
| MousePheno | abnormal pancreatic beta cell apoptosis | 6.96e-05 | 9 | 20 | 2 | MP:0014116 | |
| MousePheno | increased pancreatic islet cell apoptosis | 1.75e-04 | 14 | 20 | 2 | MP:0014121 | |
| Domain | Ald_DH_CS_GLU | 9.04e-07 | 16 | 23 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.10e-06 | 17 | 23 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.32e-06 | 18 | 23 | 3 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.32e-06 | 18 | 23 | 3 | PS00070 | |
| Domain | - | 1.56e-06 | 19 | 23 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 1.56e-06 | 19 | 23 | 3 | PF00171 | |
| Domain | Aldehyde_DH_dom | 1.56e-06 | 19 | 23 | 3 | IPR015590 | |
| Domain | - | 1.56e-06 | 19 | 23 | 3 | 3.40.309.10 | |
| Domain | Ald_DH_C | 1.56e-06 | 19 | 23 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 1.56e-06 | 19 | 23 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 1.56e-06 | 19 | 23 | 3 | IPR016161 | |
| Domain | Laminin_G_2 | 1.56e-05 | 40 | 23 | 3 | PF02210 | |
| Domain | Laminin_G | 4.82e-05 | 58 | 23 | 3 | IPR001791 | |
| Domain | - | 6.49e-05 | 10 | 23 | 2 | 4.10.1060.10 | |
| Domain | NC1_FIB | 7.92e-05 | 11 | 23 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 7.92e-05 | 11 | 23 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 7.92e-05 | 11 | 23 | 2 | PD002078 | |
| Domain | COLFI | 7.92e-05 | 11 | 23 | 2 | SM00038 | |
| Domain | COLFI | 7.92e-05 | 11 | 23 | 2 | PF01410 | |
| Domain | RRM_1 | 1.12e-04 | 208 | 23 | 4 | PF00076 | |
| Domain | RRM | 1.32e-04 | 217 | 23 | 4 | SM00360 | |
| Domain | RRM_dom | 1.57e-04 | 227 | 23 | 4 | IPR000504 | |
| Domain | RRM | 1.65e-04 | 230 | 23 | 4 | PS50102 | |
| Domain | - | 2.07e-04 | 244 | 23 | 4 | 3.30.70.330 | |
| Domain | - | 2.10e-04 | 95 | 23 | 3 | 2.60.120.200 | |
| Domain | Nucleotide-bd_a/b_plait | 2.56e-04 | 258 | 23 | 4 | IPR012677 | |
| Domain | zf-RanBP | 3.30e-04 | 22 | 23 | 2 | PF00641 | |
| Domain | TSPN | 3.61e-04 | 23 | 23 | 2 | SM00210 | |
| Domain | ZnF_RBZ | 3.61e-04 | 23 | 23 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 3.61e-04 | 23 | 23 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 3.94e-04 | 24 | 23 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 4.28e-04 | 25 | 23 | 2 | IPR001876 | |
| Domain | LAM_G_DOMAIN | 9.93e-04 | 38 | 23 | 2 | PS50025 | |
| Domain | LamG | 1.33e-03 | 44 | 23 | 2 | SM00282 | |
| Domain | ConA-like_dom | 2.37e-03 | 219 | 23 | 3 | IPR013320 | |
| Domain | Collagen | 4.87e-03 | 85 | 23 | 2 | PF01391 | |
| Domain | Collagen | 4.87e-03 | 85 | 23 | 2 | IPR008160 | |
| Pathway | KEGG_ARGININE_AND_PROLINE_METABOLISM | 7.77e-05 | 54 | 22 | 3 | M2551 | |
| Pathway | KEGG_LIMONENE_AND_PINENE_DEGRADATION | 1.04e-04 | 10 | 22 | 2 | M17395 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 4.80e-04 | 21 | 22 | 2 | M27875 | |
| Pathway | KEGG_BETA_ALANINE_METABOLISM | 5.27e-04 | 22 | 22 | 2 | M2668 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 6.82e-04 | 25 | 22 | 2 | M605 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 7.39e-04 | 26 | 22 | 2 | M907 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 9.20e-04 | 29 | 22 | 2 | M12524 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.85e-04 | 30 | 22 | 2 | M27772 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 1.19e-03 | 33 | 22 | 2 | M4086 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 1.27e-03 | 34 | 22 | 2 | M3397 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.34e-03 | 35 | 22 | 2 | M918 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 1.75e-03 | 40 | 22 | 2 | M7934 | |
| Pathway | KEGG_TRYPTOPHAN_METABOLISM | 1.75e-03 | 40 | 22 | 2 | M980 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.84e-03 | 41 | 22 | 2 | M27778 | |
| Pathway | WP_OPIOID_RECEPTOR_PATHWAYS | 1.84e-03 | 41 | 22 | 2 | M48338 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.93e-03 | 42 | 22 | 2 | M699 | |
| Pathway | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION | 2.11e-03 | 44 | 22 | 2 | M11835 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 2.11e-03 | 44 | 22 | 2 | M13720 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.11e-03 | 44 | 22 | 2 | M27812 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 2.62e-03 | 49 | 22 | 2 | M15902 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.77e-03 | 59 | 22 | 2 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.02e-03 | 61 | 22 | 2 | M27103 | |
| Pathway | REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS | 4.02e-03 | 61 | 22 | 2 | M27563 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 4.15e-03 | 62 | 22 | 2 | M11521 | |
| Pathway | WP_MRNA_PROCESSING | 4.78e-03 | 451 | 22 | 4 | MM15946 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.83e-03 | 67 | 22 | 2 | M26999 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 5.71e-03 | 73 | 22 | 2 | M39401 | |
| Pubmed | The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer. | 4.56e-07 | 2 | 24 | 2 | 24953984 | |
| Pubmed | Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. | 4.56e-07 | 2 | 24 | 2 | 9795213 | |
| Pubmed | 5.07e-07 | 23 | 24 | 3 | 18971422 | ||
| Pubmed | Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS. | 1.37e-06 | 3 | 24 | 2 | 24474660 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18620564 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27903134 | ||
| Pubmed | mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. | 1.37e-06 | 3 | 24 | 2 | 21344536 | |
| Pubmed | Characterization of a new brain-specific isoform of the EWS oncoprotein. | 1.37e-06 | 3 | 24 | 2 | 11422378 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27460707 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23975937 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23049996 | ||
| Pubmed | Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. | 1.37e-06 | 3 | 24 | 2 | 27311318 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21856723 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27415968 | ||
| Pubmed | 1.86e-06 | 35 | 24 | 3 | 33378683 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 28453628 | ||
| Pubmed | The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. | 2.74e-06 | 4 | 24 | 2 | 30398641 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 9660765 | ||
| Pubmed | Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. | 2.74e-06 | 4 | 24 | 2 | 25062688 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 27378374 | ||
| Pubmed | 5.06e-06 | 167 | 24 | 4 | 22159717 | ||
| Pubmed | Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. | 6.83e-06 | 6 | 24 | 2 | 18509338 | |
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 30354839 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.27e-05 | 8 | 24 | 2 | 33875569 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 12183049 | ||
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 24019521 | ||
| Pubmed | 1.39e-05 | 216 | 24 | 4 | 37640791 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.44e-05 | 807 | 24 | 6 | 22681889 | |
| Pubmed | 1.86e-05 | 844 | 24 | 6 | 25963833 | ||
| Pubmed | 1.94e-05 | 235 | 24 | 4 | 32614325 | ||
| Pubmed | B-1a lymphocytes promote oligodendrogenesis during brain development. | 2.05e-05 | 10 | 24 | 2 | 29507409 | |
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 33469008 | ||
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 22627280 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 2.63e-05 | 254 | 24 | 4 | 28431233 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.80e-05 | 258 | 24 | 4 | 37794589 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 3.54e-05 | 13 | 24 | 2 | 36335435 | |
| Pubmed | GDE3 regulates oligodendrocyte precursor proliferation via release of soluble CNTFRα. | 4.13e-05 | 14 | 24 | 2 | 31932351 | |
| Pubmed | Sox9 overexpression exerts multiple stage-dependent effects on mouse spinal cord development. | 4.77e-05 | 15 | 24 | 2 | 31724774 | |
| Pubmed | 4.90e-05 | 298 | 24 | 4 | 30737378 | ||
| Pubmed | 5.44e-05 | 16 | 24 | 2 | 34429415 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.48e-05 | 1024 | 24 | 6 | 24711643 | |
| Pubmed | 6.17e-05 | 17 | 24 | 2 | 32393787 | ||
| Pubmed | 6.17e-05 | 17 | 24 | 2 | 27862528 | ||
| Pubmed | The human FOXM1 homolog promotes basal progenitor cell proliferation and cortical folding in mouse. | 6.94e-05 | 18 | 24 | 2 | 34935271 | |
| Pubmed | 7.31e-05 | 118 | 24 | 3 | 21078624 | ||
| Pubmed | BACH1 changes microglial metabolism and affects astrogenesis during mouse brain development. | 9.51e-05 | 21 | 24 | 2 | 38101413 | |
| Pubmed | 1.05e-04 | 22 | 24 | 2 | 38507412 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.09e-04 | 135 | 24 | 3 | 28675934 | |
| Pubmed | 1.14e-04 | 23 | 24 | 2 | 18320585 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.14e-04 | 23 | 24 | 2 | 30962207 | |
| Pubmed | 1.17e-04 | 723 | 24 | 5 | 34133714 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.36e-04 | 25 | 24 | 2 | 19373938 | |
| Pubmed | 1.47e-04 | 26 | 24 | 2 | 35961308 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 1.96e-04 | 30 | 24 | 2 | 15782174 | |
| Pubmed | 1.98e-04 | 809 | 24 | 5 | 32129710 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 2.01e-04 | 166 | 24 | 3 | 35687106 | |
| Pubmed | 2.34e-04 | 175 | 24 | 3 | 28071719 | ||
| Pubmed | 2.38e-04 | 33 | 24 | 2 | 20301623 | ||
| Pubmed | A genome-wide association study (GWAS) for bronchopulmonary dysplasia. | 2.53e-04 | 34 | 24 | 2 | 23897914 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.55e-04 | 180 | 24 | 3 | 35198878 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.65e-04 | 462 | 24 | 4 | 31138677 | |
| Pubmed | 2.89e-04 | 878 | 24 | 5 | 37223481 | ||
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 26951610 | ||
| Pubmed | 3.12e-04 | 193 | 24 | 3 | 19343046 | ||
| Pubmed | 3.32e-04 | 197 | 24 | 3 | 21386911 | ||
| Pubmed | Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex. | 3.86e-04 | 42 | 24 | 2 | 32738194 | |
| Pubmed | 4.44e-04 | 45 | 24 | 2 | 30619335 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 4.44e-04 | 45 | 24 | 2 | 25496916 | |
| Pubmed | 4.64e-04 | 46 | 24 | 2 | 20890123 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 5.40e-04 | 558 | 24 | 4 | 35063084 | |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 6.12e-04 | 243 | 24 | 3 | 36964488 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 6.41e-04 | 247 | 24 | 3 | 32989298 | |
| Interaction | MIR98 interactions | 1.74e-06 | 78 | 23 | 4 | int:MIR98 | |
| Interaction | MIR31 interactions | 2.34e-06 | 84 | 23 | 4 | int:MIR31 | |
| Interaction | MIR128-1 interactions | 3.37e-06 | 92 | 23 | 4 | int:MIR128-1 | |
| Interaction | MIRLET7C interactions | 4.16e-06 | 97 | 23 | 4 | int:MIRLET7C | |
| Interaction | MIR363 interactions | 4.16e-06 | 97 | 23 | 4 | int:MIR363 | |
| Interaction | MIR128-2 interactions | 4.52e-06 | 99 | 23 | 4 | int:MIR128-2 | |
| Interaction | MIRLET7B interactions | 4.89e-06 | 101 | 23 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 4.89e-06 | 101 | 23 | 4 | int:MIRLET7D | |
| Interaction | MIRLET7A3 interactions | 5.09e-06 | 102 | 23 | 4 | int:MIRLET7A3 | |
| Interaction | MIR34A interactions | 5.49e-06 | 104 | 23 | 4 | int:MIR34A | |
| Interaction | MIRLET7G interactions | 8.77e-06 | 117 | 23 | 4 | int:MIRLET7G | |
| Interaction | TMUB2 interactions | 1.67e-05 | 44 | 23 | 3 | int:TMUB2 | |
| Interaction | MIR138-1 interactions | 6.20e-05 | 68 | 23 | 3 | int:MIR138-1 | |
| Interaction | MIR122 interactions | 7.05e-05 | 71 | 23 | 3 | int:MIR122 | |
| Interaction | MIR7-3 interactions | 8.65e-05 | 76 | 23 | 3 | int:MIR7-3 | |
| Interaction | MIR451A interactions | 9.34e-05 | 78 | 23 | 3 | int:MIR451A | |
| Interaction | DNAJC7 interactions | 1.00e-04 | 425 | 23 | 5 | int:DNAJC7 | |
| Interaction | MIR145 interactions | 1.05e-04 | 81 | 23 | 3 | int:MIR145 | |
| Interaction | SMU1 interactions | 1.17e-04 | 227 | 23 | 4 | int:SMU1 | |
| Interaction | MIR18B interactions | 1.21e-04 | 85 | 23 | 3 | int:MIR18B | |
| Interaction | MIR93 interactions | 1.21e-04 | 85 | 23 | 3 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 1.21e-04 | 85 | 23 | 3 | int:MIR9-1 | |
| Interaction | MIR141 interactions | 1.34e-04 | 88 | 23 | 3 | int:MIR141 | |
| Interaction | MIR200C interactions | 1.48e-04 | 91 | 23 | 3 | int:MIR200C | |
| Interaction | MIRLET7F1 interactions | 1.63e-04 | 94 | 23 | 3 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 1.73e-04 | 96 | 23 | 3 | int:MIRLET7A2 | |
| Interaction | MIR21 interactions | 1.79e-04 | 97 | 23 | 3 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.79e-04 | 97 | 23 | 3 | int:MIRLET7F2 | |
| Interaction | MIR19A interactions | 1.95e-04 | 100 | 23 | 3 | int:MIR19A | |
| Interaction | MIR25 interactions | 2.01e-04 | 101 | 23 | 3 | int:MIR25 | |
| Interaction | MIR15B interactions | 2.13e-04 | 103 | 23 | 3 | int:MIR15B | |
| Interaction | MIR19B1 interactions | 2.19e-04 | 104 | 23 | 3 | int:MIR19B1 | |
| Interaction | MIRLET7E interactions | 2.32e-04 | 106 | 23 | 3 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 2.45e-04 | 108 | 23 | 3 | int:MIRLET7A1 | |
| Interaction | RNU1-1 interactions | 2.58e-04 | 21 | 23 | 2 | int:RNU1-1 | |
| Interaction | MIR34B interactions | 2.59e-04 | 110 | 23 | 3 | int:MIR34B | |
| Interaction | MIRLET7I interactions | 2.87e-04 | 114 | 23 | 3 | int:MIRLET7I | |
| Interaction | CACNA1A interactions | 3.59e-04 | 123 | 23 | 3 | int:CACNA1A | |
| Interaction | CYB561A3 interactions | 3.68e-04 | 25 | 23 | 2 | int:CYB561A3 | |
| Interaction | YIPF2 interactions | 5.68e-04 | 31 | 23 | 2 | int:YIPF2 | |
| Interaction | ST7L interactions | 9.47e-04 | 40 | 23 | 2 | int:ST7L | |
| Interaction | AURKA interactions | 9.71e-04 | 696 | 23 | 5 | int:AURKA | |
| Interaction | KCNK16 interactions | 1.04e-03 | 42 | 23 | 2 | int:KCNK16 | |
| Interaction | PGD interactions | 1.07e-03 | 179 | 23 | 3 | int:PGD | |
| Interaction | MCM2 interactions | 1.08e-03 | 1081 | 23 | 6 | int:MCM2 | |
| Interaction | CUL4B interactions | 1.19e-03 | 728 | 23 | 5 | int:CUL4B | |
| Interaction | ACE2 interactions | 1.21e-03 | 1106 | 23 | 6 | int:ACE2 | |
| Interaction | ATN1 interactions | 1.21e-03 | 187 | 23 | 3 | int:ATN1 | |
| Interaction | DDX17 interactions | 1.27e-03 | 426 | 23 | 4 | int:DDX17 | |
| Interaction | MAPT interactions | 1.29e-03 | 1119 | 23 | 6 | int:MAPT | |
| Interaction | RNF139 interactions | 1.31e-03 | 47 | 23 | 2 | int:RNF139 | |
| Interaction | APPBP2 interactions | 1.31e-03 | 192 | 23 | 3 | int:APPBP2 | |
| GeneFamily | Aldehyde dehydrogenases | 7.95e-07 | 19 | 18 | 3 | 398 | |
| GeneFamily | RNA binding motif containing | 1.64e-06 | 213 | 18 | 5 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.94e-04 | 21 | 18 | 2 | 89 | |
| GeneFamily | Collagens | 9.44e-04 | 46 | 18 | 2 | 490 | |
| GeneFamily | Ring finger proteins | 3.00e-02 | 275 | 18 | 2 | 58 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 148 | 24 | 3 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.26e-05 | 165 | 24 | 3 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.94e-05 | 169 | 24 | 3 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.05e-04 | 172 | 24 | 3 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 174 | 24 | 3 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | facs-Liver-Non-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 177 | 24 | 3 | f73ed860685a724591d0f543a9ac4e868aff92f5 | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 179 | 24 | 3 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 180 | 24 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 180 | 24 | 3 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.24e-04 | 182 | 24 | 3 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 182 | 24 | 3 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 182 | 24 | 3 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-04 | 182 | 24 | 3 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 1.24e-04 | 182 | 24 | 3 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 182 | 24 | 3 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 1.24e-04 | 182 | 24 | 3 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-04 | 182 | 24 | 3 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 186 | 24 | 3 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 187 | 24 | 3 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 187 | 24 | 3 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 24 | 3 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 188 | 24 | 3 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 24 | 3 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 189 | 24 | 3 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 1.43e-04 | 191 | 24 | 3 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 192 | 24 | 3 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 192 | 24 | 3 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 193 | 24 | 3 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 194 | 24 | 3 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.52e-04 | 195 | 24 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 196 | 24 | 3 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-04 | 198 | 24 | 3 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 198 | 24 | 3 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.61e-04 | 199 | 24 | 3 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 1.61e-04 | 199 | 24 | 3 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-04 | 199 | 24 | 3 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-04 | 52 | 24 | 2 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 98 | 24 | 2 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 123 | 24 | 2 | e0eb95f1da12687230b47f0a7367b6138bc7ff1a | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 123 | 24 | 2 | 356e2b1b47fdfc2bb2fcd45e44b452fe811f0fd8 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 123 | 24 | 2 | 15f951b4eb2f39888e51e1af18c329953d253f7f | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1-Polydendrocyte.Tnr.Tnr_(Tnr)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 123 | 24 | 2 | b06a38d1081b4485b519853d8c9a2cddfb1e9e75 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1-Polydendrocyte.Tnr.Tnr_(Tnr)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 123 | 24 | 2 | f60c1dd89da0e204f73772fe0c319eeca82e7e8a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-03 | 128 | 24 | 2 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-03 | 131 | 24 | 2 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.26e-03 | 132 | 24 | 2 | 48449e2e95804a26f204ac7ea763dee26cf794ab | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 136 | 24 | 2 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.47e-03 | 138 | 24 | 2 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-03 | 145 | 24 | 2 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | droplet-Liver-Npc-18m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-03 | 151 | 24 | 2 | 86efabf27c264c856dca1cffacb16cef52e9863c | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-03 | 152 | 24 | 2 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.98e-03 | 152 | 24 | 2 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.02e-03 | 153 | 24 | 2 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.10e-03 | 155 | 24 | 2 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-03 | 155 | 24 | 2 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-03 | 157 | 24 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue | 3.18e-03 | 157 | 24 | 2 | c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-03 | 158 | 24 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-03 | 159 | 24 | 2 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-03 | 159 | 24 | 2 | 0f6ff73410fd6a6f97a53cb865952963a73848dd | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.29e-03 | 160 | 24 | 2 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 3.29e-03 | 160 | 24 | 2 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-03 | 160 | 24 | 2 | 6005948e400e781cdb876ba350b3ec8991e3945f | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 3.34e-03 | 161 | 24 | 2 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-03 | 162 | 24 | 2 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.38e-03 | 162 | 24 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-03 | 163 | 24 | 2 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-03 | 163 | 24 | 2 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.42e-03 | 163 | 24 | 2 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-03 | 164 | 24 | 2 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-03 | 164 | 24 | 2 | c9866a289e120be4066e66275c3beb97ba67cca4 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-03 | 164 | 24 | 2 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-03 | 164 | 24 | 2 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-03 | 165 | 24 | 2 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 3.50e-03 | 165 | 24 | 2 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| Computational | CoA and fatty acid metabolism. | 3.07e-04 | 19 | 15 | 2 | MODULE_305 | |
| Computational | Genes in the cancer module 184. | 7.22e-04 | 29 | 15 | 2 | MODULE_184 | |
| Computational | Fatty acid metabolism. | 7.73e-04 | 30 | 15 | 2 | MODULE_221 | |
| Drug | DEAB | 1.57e-06 | 23 | 23 | 3 | CID000056566 | |
| Drug | 10-CHO-THF | 1.71e-05 | 50 | 23 | 3 | CID000000010 | |
| Drug | methylglyoxal | 1.74e-05 | 157 | 23 | 4 | CID000000880 | |
| Drug | propionaldehyde | 1.82e-05 | 51 | 23 | 3 | CID000000527 | |
| Drug | N1-ethylchlorpropamide | 2.04e-05 | 7 | 23 | 2 | CID000362592 | |
| Drug | PNP dimethylcarbamate | 2.04e-05 | 7 | 23 | 2 | CID000081656 | |
| Drug | 3-butynoate | 2.04e-05 | 7 | 23 | 2 | CID000137547 | |
| Drug | 3-butynal | 2.04e-05 | 7 | 23 | 2 | CID000142966 | |
| Drug | AC1L8X1L | 2.72e-05 | 8 | 23 | 2 | CID000409504 | |
| Drug | C04554 | 2.72e-05 | 8 | 23 | 2 | CID000440384 | |
| Drug | ethylphenyl(2-formylethyl)phosphinate | 2.72e-05 | 8 | 23 | 2 | CID000151185 | |
| Drug | nitrefazole | 2.72e-05 | 8 | 23 | 2 | CID000071900 | |
| Drug | CPD 30 | 3.50e-05 | 9 | 23 | 2 | CID000440850 | |
| Drug | 4-acetamidobutyrate | 3.50e-05 | 9 | 23 | 2 | CID000018189 | |
| Drug | L 574 | 3.50e-05 | 9 | 23 | 2 | CID000067114 | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 5820_DN | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 6424_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.15e-05 | 196 | 23 | 4 | 2372_DN | |
| Drug | colcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA | 4.32e-05 | 198 | 23 | 4 | 1103_DN | |
| Drug | Me-DTC | 4.37e-05 | 10 | 23 | 2 | CID000012704 | |
| Drug | vernolate | 4.37e-05 | 10 | 23 | 2 | CID000016003 | |
| Drug | NSC85552 | 4.37e-05 | 10 | 23 | 2 | CID003000646 | |
| Drug | resorufin acetate | 4.37e-05 | 10 | 23 | 2 | CID003080579 | |
| Drug | 2-amino-4,6-dinitrotoluene | 4.72e-05 | 70 | 23 | 3 | ctd:C035208 | |
| Drug | ampal | 5.34e-05 | 11 | 23 | 2 | CID000129385 | |
| Drug | ynoate | 5.34e-05 | 11 | 23 | 2 | CID000010110 | |
| Drug | phenylketophosphamide | 6.40e-05 | 12 | 23 | 2 | CID000127726 | |
| Drug | imidazole acetaldehyde | 6.40e-05 | 12 | 23 | 2 | CID000150841 | |
| Drug | octadecanal | 7.56e-05 | 13 | 23 | 2 | CID000012533 | |
| Drug | p-nitrophenyl acetate | 7.85e-05 | 83 | 23 | 3 | CID000013243 | |
| Drug | 1-aminocyclopropanol | 8.82e-05 | 14 | 23 | 2 | CID000148676 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.02e-04 | 15 | 23 | 2 | CID000440673 | |
| Drug | carboxyphosphamide | 1.16e-04 | 16 | 23 | 2 | CID000031515 | |
| Drug | glycurone | 1.16e-04 | 16 | 23 | 2 | CID000003483 | |
| Drug | trimethylaminobutyraldehyde | 1.32e-04 | 17 | 23 | 2 | CID000000133 | |
| Drug | propynal | 1.32e-04 | 17 | 23 | 2 | CID000012222 | |
| Drug | isovanillin | 1.48e-04 | 18 | 23 | 2 | CID000012127 | |
| Drug | beta-alanine | 1.53e-04 | 104 | 23 | 3 | CID000000239 | |
| Drug | SMDM | 1.65e-04 | 19 | 23 | 2 | CID000119467 | |
| Drug | 5-HIAL | 1.65e-04 | 19 | 23 | 2 | CID000074688 | |
| Drug | perillaldehyde | 2.03e-04 | 21 | 23 | 2 | CID000016441 | |
| Drug | methacrylamide | 2.23e-04 | 22 | 23 | 2 | CID000006595 | |
| Drug | coprine | 2.23e-04 | 22 | 23 | 2 | CID000108079 | |
| Drug | aldophosphamide | 2.66e-04 | 24 | 23 | 2 | CID000107744 | |
| Drug | 2-cyano-3-phenylacrylic acid | 2.89e-04 | 25 | 23 | 2 | CID000070534 | |
| Drug | gamma-aminobutyraldehyde | 2.89e-04 | 25 | 23 | 2 | CID000000118 | |
| Drug | 4-methylpiperazine-2,6-dione | 3.13e-04 | 26 | 23 | 2 | CID000124723 | |
| Drug | AC1L3LTR | 3.37e-04 | 27 | 23 | 2 | CID000142774 | |
| Drug | 5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate | 3.37e-04 | 27 | 23 | 2 | ctd:C521334 | |
| Drug | indole-3-acetaldehyde | 3.63e-04 | 28 | 23 | 2 | CID000000800 | |
| Drug | formalin | 3.92e-04 | 143 | 23 | 3 | CID000000712 | |
| Drug | phosphoramide mustard | 4.17e-04 | 30 | 23 | 2 | CID000096356 | |
| Drug | 3,4-dihydroxyphenylacetaldehyde | 4.17e-04 | 30 | 23 | 2 | CID000119219 | |
| Drug | 3-aminopropanal | 4.17e-04 | 30 | 23 | 2 | CID000000075 | |
| Drug | decanal | 4.46e-04 | 31 | 23 | 2 | CID000008175 | |
| Drug | perillic acid | 4.46e-04 | 31 | 23 | 2 | CID000001256 | |
| Drug | A-skin | 4.75e-04 | 32 | 23 | 2 | CID000208772 | |
| Drug | methylmalonate semialdehyde | 4.75e-04 | 32 | 23 | 2 | CID000000296 | |
| Drug | betaine aldehyde | 4.75e-04 | 32 | 23 | 2 | CID000000249 | |
| Drug | lactaldehyde | 4.75e-04 | 32 | 23 | 2 | CID000000855 | |
| Drug | daidzin | 5.06e-04 | 33 | 23 | 2 | CID000107971 | |
| Drug | a-ET | 5.37e-04 | 34 | 23 | 2 | CID000002039 | |
| Drug | EMCs | 5.37e-04 | 34 | 23 | 2 | CID005091655 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 5.64e-04 | 162 | 23 | 3 | CID000072363 | |
| Drug | pyrroline | 5.69e-04 | 35 | 23 | 2 | CID000094395 | |
| Drug | EPTC | 5.69e-04 | 35 | 23 | 2 | CID000012968 | |
| Drug | furfural | 6.02e-04 | 36 | 23 | 2 | CID000007362 | |
| Drug | AC1L3Y54 | 6.02e-04 | 36 | 23 | 2 | CID000124259 | |
| Drug | octanal | 6.36e-04 | 37 | 23 | 2 | CID000000454 | |
| Drug | 4-hydroxycyclophosphamide | 6.71e-04 | 38 | 23 | 2 | CID000099735 | |
| Drug | Creosote | 6.71e-04 | 38 | 23 | 2 | ctd:D003407 | |
| Drug | DETC-MeSO | 7.07e-04 | 39 | 23 | 2 | CID003035711 | |
| Drug | AC1L4U4B | 7.44e-04 | 40 | 23 | 2 | CID000164062 | |
| Drug | gamma-butyrobetaine | 8.20e-04 | 42 | 23 | 2 | CID000000134 | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 6728_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 2690_DN | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HG-U133A | 9.37e-04 | 193 | 23 | 3 | 201_UP | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; HL60; HG-U133A | 9.37e-04 | 193 | 23 | 3 | 2040_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5639_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2374_DN | |
| Drug | NSC626779 | 9.83e-04 | 46 | 23 | 2 | CID000116733 | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2366_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4986_DN | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2922_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4966_DN | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 1.01e-03 | 198 | 23 | 3 | 961_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 3236_DN | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 1.90e-06 | 3 | 24 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 4.16e-05 | 12 | 24 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 2.72e-04 | 30 | 24 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | bronchopulmonary dysplasia | 6.14e-04 | 45 | 24 | 2 | MONDO_0019091 | |
| Disease | metabolite measurement | 1.01e-03 | 560 | 24 | 4 | EFO_0004725 | |
| Disease | Amyotrophic Lateral Sclerosis | 1.02e-03 | 58 | 24 | 2 | C0002736 | |
| Disease | waist circumference | 4.92e-03 | 429 | 24 | 3 | EFO_0004342 | |
| Disease | PR interval | 7.31e-03 | 495 | 24 | 3 | EFO_0004462 | |
| Disease | heel bone mineral density, urate measurement | 9.55e-03 | 182 | 24 | 2 | EFO_0004531, EFO_0009270 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFGGYKKSGFGRENG | 456 | P49189 | |
| GGGFPGTEGAKVRFE | 236 | Q96A70 | |
| CGGERFGERGFFIKP | 386 | P30837 | |
| PFGGFKESGNGRELG | 481 | P30837 | |
| VNFGRPEGGKFDFGK | 886 | Q8IXT5 | |
| RGGFKNFGGHRDYGP | 206 | Q92804 | |
| FGLVGGRPEFRFDAG | 3726 | P98160 | |
| QDKGGFGFRKGGPDD | 121 | Q15056 | |
| SGFGFRILGGDEPGQ | 786 | Q86UL8 | |
| GFREGQQYGRGKSGG | 116 | A6PVI3 | |
| GGGQEERPFVARFGF | 131 | Q9HA64 | |
| RGGMGGSDRGGFNKF | 251 | P35637 | |
| GSDRGGFNKFGGPRD | 256 | P35637 | |
| LFDEFKGGRPGGFPD | 41 | O00625 | |
| GDKPGRQFDGSAFGA | 111 | Q6UUV7 | |
| GRFFGGDRGAPKRGS | 176 | P02686 | |
| GGFFPQGKPRQCGDF | 281 | Q8WWU7 | |
| ARAVGFGGDFDGVPR | 296 | P16444 | |
| PGLFGQKGDDGVRGF | 1126 | P25940 | |
| ESRGGFQPFGDTGGF | 106 | Q99942 | |
| EAPNRGFFKGLFGGG | 1041 | Q5T5C0 | |
| PFGGFKQSGFGKDLG | 871 | O75891 | |
| GRAGRPQFDKFGEGI | 851 | Q8N3C0 | |
| FKGRQGFPGDFGDRG | 646 | Q17RW2 | |
| FDGLLGFPGGFVDRR | 56 | Q9BRJ7 | |
| EPENRGGFQGFGFGD | 116 | Q96GF1 |